ARCHIVES

FDA Guidance for Public Comment at Advisory Committee Meetings

This article is from The Cancer Letter archive.

Vol. 36 No. 45 | December 10, 2010

Download PDF Visit The Full Archive

Related Articles

DOD Names Innovator Award Recipients.

April 26, 2002

Conversation With The Cancer Letter: Wicha to Leave Director’s Job at UMich

November 8, 2013

No Evidence Of Fraud Found In NCI Audit Of NSABP Trials

April 29, 1994

NCI To Recompete NSABP in 1995, Chabner tells Senate

May 20, 1994

CTEP Publishes Final Version of Plan for Assigning Intellectual Property Rights On Correlative Research

April 8, 2011

FDA Puts Clinical Hold On Gene Therapy Trials

January 24, 2003